For example, knocking down FOXM1 or STAT3 in proximal models may reduce tumor growth [30], while overexpressing CDX2 or GATA6 could induce a more differentiated, less aggressive phenotype, advancing therapeutic understanding and precision medicine [63]. The gene discussed is CDX2; the disease is neoplasm.